These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 18632623

  • 1. Temozolomide preferentially depletes cancer stem cells in glioblastoma.
    Beier D, Röhrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, Giebel B, Wischhusen J, Reifenberger G, Hau P, Beier CP.
    Cancer Res; 2008 Jul 15; 68(14):5706-15. PubMed ID: 18632623
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines.
    Beier D, Schriefer B, Brawanski K, Hau P, Weis J, Schulz JB, Beier CP.
    J Neurooncol; 2012 Aug 15; 109(1):45-52. PubMed ID: 22544650
    [Abstract] [Full Text] [Related]

  • 3. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
    Donson AM, Addo-Yobo SO, Handler MH, Gore L, Foreman NK.
    Pediatr Blood Cancer; 2007 Apr 15; 48(4):403-7. PubMed ID: 16609952
    [Abstract] [Full Text] [Related]

  • 4. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.
    Perazzoli G, Prados J, Ortiz R, Caba O, Cabeza L, Berdasco M, Gónzalez B, Melguizo C.
    PLoS One; 2015 Apr 15; 10(10):e0140131. PubMed ID: 26447477
    [Abstract] [Full Text] [Related]

  • 5. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
    Miao W, Liu X, Wang H, Fan Y, Lian S, Yang X, Wang X, Guo G, Li Q, Wang S.
    Mol Med Rep; 2015 Jun 15; 11(6):4165-73. PubMed ID: 25625235
    [Abstract] [Full Text] [Related]

  • 6. Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.
    William D, Walther M, Schneider B, Linnebacher M, Classen CF.
    PLoS One; 2018 Jun 15; 13(1):e0191511. PubMed ID: 29352318
    [Abstract] [Full Text] [Related]

  • 7. JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.
    Okada M, Sato A, Shibuya K, Watanabe E, Seino S, Suzuki S, Seino M, Narita Y, Shibui S, Kayama T, Kitanaka C.
    Int J Oncol; 2014 Feb 15; 44(2):591-9. PubMed ID: 24316756
    [Abstract] [Full Text] [Related]

  • 8. Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.
    Beier D, Schulz JB, Beier CP.
    Mol Cancer; 2011 Oct 11; 10():128. PubMed ID: 21988793
    [Abstract] [Full Text] [Related]

  • 9. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
    Banelli B, Carra E, Barbieri F, Würth R, Parodi F, Pattarozzi A, Carosio R, Forlani A, Allemanni G, Marubbi D, Florio T, Daga A, Romani M.
    Cell Cycle; 2015 Oct 11; 14(21):3418-29. PubMed ID: 26566863
    [Abstract] [Full Text] [Related]

  • 10. STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression.
    Kohsaka S, Wang L, Yachi K, Mahabir R, Narita T, Itoh T, Tanino M, Kimura T, Nishihara H, Tanaka S.
    Mol Cancer Ther; 2012 Jun 11; 11(6):1289-99. PubMed ID: 22532597
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S, Takahashi K, Wang L, Tanino M, Kimura T, Nishihara H, Tanaka S.
    Cancer Lett; 2013 Apr 30; 331(1):68-75. PubMed ID: 23246370
    [Abstract] [Full Text] [Related]

  • 12. Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells.
    Happold C, Roth P, Wick W, Schmidt N, Florea AM, Silginer M, Reifenberger G, Weller M.
    J Neurochem; 2012 Jul 30; 122(2):444-55. PubMed ID: 22564186
    [Abstract] [Full Text] [Related]

  • 13. The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells.
    Clark PA, Gaal JT, Strebe JK, Pasch CA, Deming DA, Kuo JS, Robins HI.
    J Clin Neurosci; 2017 Feb 30; 36():120-124. PubMed ID: 27865821
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
    Tian T, Mingyi M, Qiu X, Qiu Y.
    Oncotarget; 2016 Nov 29; 7(48):79584-79595. PubMed ID: 27792996
    [Abstract] [Full Text] [Related]

  • 15. N3-substituted temozolomide analogs overcome methylguanine-DNA methyltransferase and mismatch repair precipitating apoptotic and autophagic cancer cell death.
    Zhang J, Hummersone M, Matthews CS, Stevens MF, Bradshaw TD.
    Oncology; 2015 Nov 29; 88(1):28-48. PubMed ID: 25277441
    [Abstract] [Full Text] [Related]

  • 16. Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression.
    Zhao Y, Xiao Z, Chen W, Yang J, Li T, Fan B.
    Mol Med Rep; 2015 Aug 29; 12(2):2313-22. PubMed ID: 25937029
    [Abstract] [Full Text] [Related]

  • 17. Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics.
    St-Coeur PD, Poitras JJ, Cuperlovic-Culf M, Touaibia M, Morin P.
    J Neurooncol; 2015 Oct 29; 125(1):91-102. PubMed ID: 26311249
    [Abstract] [Full Text] [Related]

  • 18. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G, Sun Y, Hong R, Xiong J, Lu Y, Liu Y, Lu J, Zhang Z, Guo C, Nan Y, Huang Q.
    Clin Transl Oncol; 2020 Aug 29; 22(8):1252-1262. PubMed ID: 31865606
    [Abstract] [Full Text] [Related]

  • 19. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.
    Johannessen TC, Prestegarden L, Grudic A, Hegi ME, Tysnes BB, Bjerkvig R.
    Neuro Oncol; 2013 Mar 29; 15(3):269-78. PubMed ID: 23258843
    [Abstract] [Full Text] [Related]

  • 20. Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase.
    Chang KY, Hsu TI, Hsu CC, Tsai SY, Liu JJ, Chou SW, Liu MS, Liou JP, Ko CY, Chen KY, Hung JJ, Chang WC, Chuang CK, Kao TJ, Chuang JY.
    Redox Biol; 2017 Oct 29; 13():655-664. PubMed ID: 28822335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.